Seizure Detection With a Deep Brain Stimulation System

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the in-patient setting (epilepsy monitoring unit), in 5 patients with drug resistant epilepsy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Participants must meet all of the inclusion criteria to participate in this study:

• 18 years of age and older.

• Implanted with a clinical DBS system for epilepsy with brain recording capabilities (Medtronic Percept™ DBS).

• Subject or legally authorized representative is able to understand study procedures and to comply with them for the entire length of the study.

Locations
United States
Minnesota
Mayo Clinic in Rochester
RECRUITING
Rochester
Contact Information
Primary
Karla Crockett
crockett.karla@mayo.edu
507-538-4880
Time Frame
Start Date: 2026-01-01
Estimated Completion Date: 2027-05
Participants
Target number of participants: 5
Treatments
Experimental: Thalamus seizure detection with a DBS system
Thalamus seizure detection by a DBS system, validated with concurrent in-hospital gold standard video EEG monitoring.
Sponsors
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov

Similar Clinical Trials